STAT3 Therapeutics is an early stage oncology-focused company, dedicated to developing and commercializing drugs that target the activated STAT3 molecule. Their unique approach arrests the activity of the STAT3 dimer using a cyclic decoy that binds to the molecule in a way that is both specific and impactful, without significant toxic side effects.
Location: United States, Florida, Coral Springs
Investors 1
| Date | Name | Website |
| - | University... | innovation... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 21.05.2019 | 4 things to know in #MiamiTech: More winners, an acquisition... | Facebook Tweet Pin LinkedIn Email 1 South Florida startups win big at Florida Early Stage Capit... | refreshmia... |
| 07.05.2019 | 4 things to know in #MiamiTech: Who's pitching next, co-work... | Facebook Tweet Pin LinkedIn Email 1 General Provision opens downtown Fort Lauderdale location ... | refreshmia... |